Eli Lilly

+$5.38 (+1.69%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.

CEO

David A. Ricks

Employees

35,000

Headquarters

Indianapolis, Indiana

Founded

1876

LLY Key Statistics

Market cap

Price-Earnings ratio

47.10

Dividend yield

1.15

Average volume

3.66M

High today

$324.70

Low today

$317.69

Open price

$318.16

Volume

2.56M

52 Week high

$330.85

52 Week low

$220.20

LLY News

Benzinga9h

If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today

Eli Lilly LLY has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 31.32%. Currently, Eli Li

Reuters20h

Eli Lilly to supply additional doses of COVID antibody drug to U.S.

June 29 (Reuters) - Eli Lilly and Co said on Wednesday it will supply additional doses of its COVID-19 antibody drug to the U.S. government in order to meet dem

MarketWatch20h

Eli Lilly Gets $275 Million U.S. Pact for Covid-19 Antibody Drug >LLY - MarketWatch

By Colin Kellaher Eli Lilly & Co. on Wednesday said it agreed to supply an additional 150,000 doses of its Covid-19 antibody drug bebtelovimab to the U.S. gove

Analyst ratings

Buy

61.5%

Hold

30.8%

Sell

7.7%

LLY Earnings

$0.00

$0.92

$1.83

$2.75

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Available Aug 4, Pre-Market

More LLY News

MarketWatch20h

Eli Lilly to supply another 150,000 doses of COVID treatment to the government

Eli Lilly & Co. LLY, -2.95% said Wednesday that it will supply the U.S. government with an additional 150,000 doses of its COVID treatment bebtelovimab for abou

Simply Wall StJun 28

Eli Lilly's five-year earnings growth trails the 34% YoY shareholder returns

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on the bright side, you can

CNBCJun 23

We're trimming a winner we still believe in to raise some cash and right-size our position

We're selling 100 shares of Eli Lilly (LLY) at roughly $311.78 each. Following Thursday's trade, the portfolio will own 350 shares of LLY — decreasing its weigh